Depression Care360
Andrew Penn, MS, PMHNP.
Depression Care360
11/02/2022
Andrew Penn, MS, PMHNP, explains why psychedelic-assisted therapies are a great option for treating depression.
11/02/2022
Depression Care360
Andrew Penn, MS, PMHNP.
Depression Care360
11/02/2022
Andrew Penn, MS, PMHNP, explains why psychedelic-assisted therapies are a great option for treating depression.
11/02/2022
Depression Care360
Depression Care360
10/24/2022
Manish K. Jha, MBBS, and Saundra Jain, MA, PsyD, LPC, discuss their Psych Congress 2022 session "Measurement-Based Care in Depression and Beyond: What is it and how to make it work for your patients?" and...
10/24/2022
Depression Care360
Depression Care360
10/24/2022
Manish K. Jha, MBBS, and Saundra Jain, MA, PsyD, LPC, discuss their Psych Congress 2022 session "Measurement-Based Care in Depression and Beyond: What is it and how to make it work for your patients?" and...
10/24/2022
Depression Care360
Michael B. FIrst, MD.
Depression Care360
08/02/2022
Michael B. First, MD, professor of clinical psychiatry, editor & co-chair, DSM-5-TR, explains new depression diagnostic criteria that have been incorporated, offers insights on how the updated text will...
08/02/2022
Depression Care360
Michael B. FIrst, MD.
Depression Care360
08/02/2022
Michael B. First, MD, professor of clinical psychiatry, editor & co-chair, DSM-5-TR, explains new depression diagnostic criteria that have been incorporated, offers insights on how the updated text will...
08/02/2022
Q&A Insights From Psych Congress Regionals
Q&A Insights From Psych Congress Regionals
Q&A Insights From Psych Congress Regionals
Q&A Insights From Psych Congress Regionals
Depression Care360
Depression Care360
04/18/2022
Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the...
04/18/2022
Depression Care360
Depression Care360
04/18/2022
Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the...
04/18/2022